Selective Upregulation of Fibroblast Fas Ligand Expression, and Prolongation of Fas/Fas Ligand-Mediated Skin Allograft Survival, by Retinoic Acid: the Skin as a Retinoide-Inducible Immune Privilege Site
- 1 August 2000
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 115 (2) , 154-161
- https://doi.org/10.1046/j.1523-1747.2000.00062.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of proliferation and CD25 down-regulation by retinoic acid in human adult T cell leukemia cellsLeukemia, 1997
- Retinoic Acid-induced Transcriptional Modulation of the Human Interferon-γ PromoterPublished by Elsevier ,1996
- Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in MiceScience, 1996
- CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological ToleranceImmunity, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- Ways around rejectionNature, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Mutations in Fas Associated with Human Lymphoproliferative Syndrome and AutoimmunityScience, 1995
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995